Skip to main content

DeLuca Richard R.'s Form 4 filing

Merck & Co., Inc. (MRK) · filed May 2, 2023

Accession no.
0001127602-23-014025
Filed
May 2, 2023
Trade date
Apr 28-May 1, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $16.4M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
DeLuca Richard R.CIK 0001421339Officer (EVP&Pres, Merck Animal Heallth)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2023Common StockMOption exerciseAcquired+66,163$62.07+$4,106,737.41220,655.85Direct
Apr 28, 2023Common StockSSaleDisposed−66,163$115.00−$7,608,745154,492.85Direct
May 1, 2023Common StockMOption exerciseAcquired+75,436$56.04+$4,227,433.44229,928.85Direct
May 1, 2023Common StockSSaleDisposed−75,436$116.03−$8,752,839.08154,492.85Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 28, 2023Common StockMOption exerciseDisposed−66,163$0.00$00Direct
May 1, 2023Common StockMOption exerciseDisposed−75,436$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)